These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 572399)

  • 41. The development of neurotropism in Rift Valley fever virus.
    KITCHEN SF
    Ann Trop Med Parasitol; 1950 Jul; 44(2):132-45. PubMed ID: 24537996
    [No Abstract]   [Full Text] [Related]  

  • 42. The clinical picture of Rift Valley fever in Egypt.
    Boctor WM
    J Egypt Public Health Assoc; 1978; 53(3-4):177-80. PubMed ID: 572397
    [No Abstract]   [Full Text] [Related]  

  • 43. Notes on Rift Valley fever.
    FINDLAY GM; HOWARD EM
    Arch Gesamte Virusforsch; 1951; 4(4):411-23. PubMed ID: 13249478
    [No Abstract]   [Full Text] [Related]  

  • 44. Different-sized infective particles of Rift Valley fever virus.
    NAUDE Wdu T; MADSEN T; POLSON A
    Nature; 1954 May; 173(4413):1051-2. PubMed ID: 13165719
    [No Abstract]   [Full Text] [Related]  

  • 45. Outbreak of Rift Valley fever, Yemen, August-October 2000.
    Wkly Epidemiol Rec; 2000 Dec; 75(48):392-5. PubMed ID: 11144616
    [No Abstract]   [Full Text] [Related]  

  • 46. Rift Valley fever virus: A review of diagnosis and vaccination, and implications for emergence in Europe.
    Mansfield KL; Banyard AC; McElhinney L; Johnson N; Horton DL; Hernández-Triana LM; Fooks AR
    Vaccine; 2015 Oct; 33(42):5520-5531. PubMed ID: 26296499
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidemic Rift Valley fever in Saudi Arabia: a clinical study of severe illness in humans.
    Al-Hazmi M; Ayoola EA; Abdurahman M; Banzal S; Ashraf J; El-Bushra A; Hazmi A; Abdullah M; Abbo H; Elamin A; Al-Sammani el-T; Gadour M; Menon C; Hamza M; Rahim I; Hafez M; Jambavalikar M; Arishi H; Aqeel A
    Clin Infect Dis; 2003 Feb; 36(3):245-52. PubMed ID: 12539063
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A brain factor influencing the viability of neurotropic Rift Valley fever.
    POLSON A; MADSEN TI
    Nature; 1955 Oct; 176(4483):645-6. PubMed ID: 13265798
    [No Abstract]   [Full Text] [Related]  

  • 49. Notes from the Field: Rift Valley Fever Response - Kabale District, Uganda, March 2016.
    de St Maurice A; Nyakarahuka L; Purpura L; Ervin E; Tumusiime A; Balinandi S; Kayondo J; Mulei S; Namutebi AM; Tusiime P; Wiersma S; Nichol S; Rollin P; Klena J; Knust B; Shoemaker T
    MMWR Morb Mortal Wkly Rep; 2016 Nov; 65(43):1200-1201. PubMed ID: 27811840
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rift Valley Fever virus infections in Egypt: Pathological and virological findings in man.
    Abdel-Wahab KS; El Baz LM; El-Tayeb EM; Omar H; Ossman MA; Yasin W
    Trans R Soc Trop Med Hyg; 1978; 72(4):392-6. PubMed ID: 568328
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plaque formation with Rift Valley fever virus.
    TAKEMORI N; NAKANO M; HEMMI M
    Virology; 1955 Jul; 1(2):250-1. PubMed ID: 13267991
    [No Abstract]   [Full Text] [Related]  

  • 52. Rift Valley fever in rural northern Senegal: human risk factors and potential vectors.
    Wilson ML; Chapman LE; Hall DB; Dykstra EA; Ba K; Zeller HG; Traore-Lamizana M; Hervy JP; Linthicum KJ; Peters CJ
    Am J Trop Med Hyg; 1994 Jun; 50(6):663-75. PubMed ID: 7912905
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Destruction of tumour cells by Rift Valley fever virus.
    TAKEMORI N; NAKANO M; HEMMI M; IKEDA H; YANAGIDA S; KITAOKA M
    Nature; 1954 Oct; 174(4432):698-700. PubMed ID: 13213987
    [No Abstract]   [Full Text] [Related]  

  • 54. Multiplication of Rift Valley fever virus in human liver cell culture with special reference to production complement fixing antigen.
    IWASA S
    Jpn J Exp Med; 1959 Aug; 29():323-34. PubMed ID: 14406176
    [No Abstract]   [Full Text] [Related]  

  • 55. Epidemic of Rift Valley fever (RVF) in Egypt: virological diagnosis of RVF in man.
    Imam IZ; Darwish MA; Karamany RE
    J Egypt Public Health Assoc; 1978; 53(3-4):205-8. PubMed ID: 572405
    [No Abstract]   [Full Text] [Related]  

  • 56. High risk for human exposure to Rift Valley fever virus in communities living along livestock movement routes: A cross-sectional survey in Kenya.
    Tigoi C; Sang R; Chepkorir E; Orindi B; Arum SO; Mulwa F; Mosomtai G; Limbaso S; Hassan OA; Irura Z; Ahlm C; Evander M
    PLoS Negl Trop Dis; 2020 Feb; 14(2):e0007979. PubMed ID: 32084127
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The fevers of Africa. III. Rift Valley Fever.
    GEAR J; SCHRIRE L
    Cent Afr J Med; 1956 Jun; 2(6):237-40. PubMed ID: 13356308
    [No Abstract]   [Full Text] [Related]  

  • 58. Lymphoplasmacytic endotheliitis and anterior uveitis in sheep infected experimentally with rift valley fever virus.
    Galindo-Cardiel I; Busquets N; Velarde R; Abad FX; Solanes D; Rivas R; Valle R; Brun A; Domingo M
    J Comp Pathol; 2012 Jan; 146(1):40-3. PubMed ID: 21601870
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rift Valley fever, Saudi Arabia, August-October 2000.
    Wkly Epidemiol Rec; 2000 Nov; 75(46):370-1. PubMed ID: 11143817
    [No Abstract]   [Full Text] [Related]  

  • 60. IgG-sandwich and IgM-capture enzyme-linked immunosorbent assay for the detection of antibody to Rift Valley fever virus in domestic ruminants.
    Paweska JT; Burt FJ; Anthony F; Smith SJ; Grobbelaar AA; Croft JE; Ksiazek TG; Swanepoel R
    J Virol Methods; 2003 Nov; 113(2):103-12. PubMed ID: 14553896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.